Cardiovascular outcomes after percutaneous coronary intervention on bifurcation lesions with moderate to severe coronary calcium: Asingle-centerregistry study

被引:4
|
作者
Murphy, Jonathan Luke
Patel, Nileshkumar
Vengrenyuk, Yuliya
Okamoto, Naotaka
Barman, Nitin
Sweeny, Joseph
Kapur, Vishal
Hasan, Choudhury
Krishnan, Prakash
Vijay, Pooja
Jhaveri, Vaishvi
Dangas, George
Mehran, Roxana
Aquino, Melissa
Baber, Usman
Sharma, Samin K.
Kini, Annapoorna S.
机构
[1] Mt Sinai Hosp, Cardiovasc Inst, New York, NY 10029 USA
[2] Icahn Sch Med Mt Sinai, New York, NY 10029 USA
关键词
bifurcation lesion; coronary calcification; percutaneous coronary intervention; DRUG-ELUTING STENTS; ACUTE MYOCARDIAL-INFARCTION; DUAL ANTIPLATELET THERAPY; ARTERY-DISEASE; ROTATIONAL ATHERECTOMY; HARMONIZING OUTCOMES; CLINICAL-OUTCOMES; POOLED ANALYSIS; REVASCULARIZATION; IMPACT;
D O I
10.1002/ccd.29069
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Both target vessel calcification and target vessel bifurcation are associated with worse outcomes following percutaneous coronary intervention (PCI). Whether these entities in combination interact to influence outcomes after PCI of complex coronary disease is not known. Objectives This study evaluated the association of target vessel bifurcation and target vessel calcification, alone and in combination, with adverse events following PCI. Methods Registry data from 21,165 patients who underwent PCI with drug-eluting stents (DES) between January 2009 and December 2017 were analyzed. Patients were divided into four groups according to the presence or absence of target vessel bifurcation and presence of none/mild or moderate/severe target vessel calcification on angiography. Associations between lesion groups and 1 year major adverse cardiac events (MACE) were examined using Cox regression analysis. Results At 1 year, unadjusted rates of MACE, death, myocardial infarction (MI), as well as stent thrombosis were highest in the group with both bifurcation lesion and moderate/severe calcification. After adjusting for confounders such as age, renal disease, and smoking, hazard ratios for MACE were 1.14 (95%CI 0.99-1.33) for bifurcation with none/mild calcification, 1.21 (95%CI 1.06-1.38) for no bifurcation and moderate/severe calcification, and 1.37 (95%CI 1.14-1.64) for bifurcation and moderate severe calcification, compared to patients with no bifurcation and none/mild calcification. Conclusions The presence of a bifurcating target vessel with moderate/severe calcification is associated with a higher risk of adverse outcomes than either attribute alone. New approaches are needed to improve outcomes in this subset of patients with complex coronary artery disease.
引用
收藏
页码:35 / 42
页数:8
相关论文
共 50 条
  • [1] Percutaneous Coronary Intervention for Coronary Bifurcation Lesions
    Finch, William
    Lee, Michael S.
    REVIEWS IN CARDIOVASCULAR MEDICINE, 2017, 18 (02) : 59 - 66
  • [2] Smoking and cardiovascular outcomes after percutaneous coronary intervention: a Korean study
    Ki, You-Jeong
    Han, Kyungdo
    Kim, Hyo-Soo
    Han, Jung-Kyu
    EUROPEAN HEART JOURNAL, 2023, 44 (42) : 4461 - 4472
  • [3] Antithrombotic therapy after percutaneous coronary intervention of bifurcation lesions
    Zimarino, Marco
    Angiolillo, Dominick J.
    Dangas, George
    Capodanno, Davide
    Barbato, Emanuele
    Hahn, Joo-Yong
    Giustino, Gennaro
    Watanabe, Hirotoshi
    Costa, Francesco
    Cuisset, Thomas
    Rossini, Roberta
    Sibbing, Dirk
    Burzotta, Francesco
    Louvard, Yves
    Shehab, Abdulla
    Renda, Giulia
    Kimura, Takeshi
    Gwon, Hyeon-Cheol
    Chen, Shao-Liang
    Costa, Ricardo
    Koo, Bon-Kwon
    Storey, Robert F.
    Valgimigli, Marco
    Mehran, Roxana
    Stankovic, Goran
    EUROINTERVENTION, 2021, 17 (01) : 59 - +
  • [4] Impact of calcified bifurcation lesions in patients undergoing percutaneous coronary intervention using drug-eluting stents: results from the COronary BIfurcation Stent (COBIS) II registry
    Kim, Min Chul
    Ahn, Youngkeun
    Sim, Doo Sun
    Hong, Young Joon
    Kim, Ju Han
    Jeong, Myung Ho
    Gwon, Hyeon-Cheol
    Kim, Hyo-Soo
    Rha, Seung Woon
    Yoon, Jung Han
    Jang, Yangsoo
    Tahk, Seung-Jea
    Seung, Ki Bea
    EUROINTERVENTION, 2017, 13 (03) : 338 - 344
  • [5] Percutaneous coronary intervention of bifurcation lesions and platelet reactivity
    Redfors, Bjorn
    Genereux, Philippe
    Witzenbichler, Bernhard
    Kirtane, Ajay J.
    Maehara, Akiko
    Weisz, Giora
    Madhavan, Mahesh V.
    McAndrew, Thomas
    Mehran, Roxana
    Stone, Gregg W.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2018, 250 : 92 - 97
  • [6] Percutaneous coronary intervention of bifurcation lesions
    Hildick-Smith, David
    Arunothayaraj, Sandeep
    Stankovic, Goran
    Chen, Shao-Liang
    EUROINTERVENTION, 2022, 18 (04) : E273 - E291
  • [7] Outcomes after Percutaneous Coronary Intervention in Patients with Extremely Calcified Left Main Lesions
    Dumitrascu, Silviu
    Bartos, Daniela
    Ungureanu, Claudiu
    MEDICINA-LITHUANIA, 2023, 59 (05):
  • [8] Clinical Outcomes of Percutaneous Coronary Intervention for Bifurcation Lesions According to Medina Classification
    Mohamed, Mohamed O.
    Lamellas, Pablo
    Roguin, Ariel
    Oemrawsingh, Rohit M.
    Ijsselmuiden, Alexander J. J.
    Routledge, Helen
    van Leeuwen, Frank
    Debrus, Roxane
    Roffi, Marco
    Mamas, Mamas A.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2022, 11 (17):
  • [9] Crush techniques for percutaneous coronary intervention of bifurcation lesions
    Moroni, Francesco
    Yeh, James Shue-Min
    Attallah, Antonious
    Santiago, Ricardo
    Martins Filho, Evandro
    Hall, Jack
    Bangalore, Sripal
    Azzalini, Lorenzo
    EUROINTERVENTION, 2022, 18 (01) : 71 - 82
  • [10] Effect of Paclitaxel-Coated Balloon Angioplasty on Side Branch Lesion and Cardiovascular Outcomes in Patients with De Novo True Coronary Bifurcation Lesions Undergoing Percutaneous Coronary Intervention
    Li, Youmei
    Mao, Qi
    Liu, Huanyun
    Zhou, Denglu
    Zhao, Jianhua
    CARDIOVASCULAR DRUGS AND THERAPY, 2022, 36 (05) : 859 - 866